WEE1 and hereditary clear cell renal cell carcinoma: <h4>Background</h4>Pazopanib hydrochloride (PZB) is a protein kinase inhibitor approved by the United States Food and Drug Administration and European agencies for the treatment of renal cell carcinoma and other renal malignancies.